BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10644883)

  • 1. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
    Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
    Suana AJ; Tuffin G; Frey BM; Knudsen L; Mühlfeld C; Rödder S; Marti HP
    J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte injuries exacerbate mesangial proliferative glomerulonephritis.
    Morioka Y; Koike H; Ikezumi Y; Ito Y; Oyanagi A; Gejyo F; Shimizu F; Kawachi H
    Kidney Int; 2001 Dec; 60(6):2192-204. PubMed ID: 11737593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
    Schuler W; Sedrani R; Cottens S; Häberlin B; Schulz M; Schuurman HJ; Zenke G; Zerwes HG; Schreier MH
    Transplantation; 1997 Jul; 64(1):36-42. PubMed ID: 9233698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
    Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
    J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis.
    Chiang CK; Sheu ML; Hung KY; Wu KD; Liu SH
    Kidney Int; 2006 Aug; 70(4):682-9. PubMed ID: 16807544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid: a new approach to the therapy of experimental mesangial proliferative glomerulonephritis.
    Ziswiler R; Steinmann-Niggli K; Kappeler A; Daniel C; Marti HP
    J Am Soc Nephrol; 1998 Nov; 9(11):2055-66. PubMed ID: 9808091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat.
    Wittmann S; Daniel C; Braun A; Vogelbacher R; Shimizu F; Kawachi H; Hugo C
    Nephron Exp Nephrol; 2008; 108(2):e45-56. PubMed ID: 18270495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
    Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
    J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
    Wu SH; Wu XH; Liao PY; Dong L
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
    Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
    J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.